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Abstract
Carboxypeptidase A6 (CPA6) is an extracellular protease that cleaves carboxy-terminal hydrophobic amino acids and has
been implicated in the defective innervation of the lateral rectus muscle by the VIth cranial nerve in Duane syndrome. In
order to investigate the role of CPA6 in development, in particular its potential role in axon guidance, the zebrafish ortholog
was identified and cloned. Zebrafish CPA6 was secreted and interacted with the extracellular matrix where it had a neutral
pH optimum and specificity for C-terminal hydrophobic amino acids. Transient mRNA expression was found in newly
formed somites, pectoral fin buds, the stomodeum and a conspicuous condensation posterior to the eye. Markers showed
this tissue was not myogenic in nature. Rather, the CPA6 localization overlapped with a chondrogenic site which
subsequently forms the walls of a myodome surrounding the lateral rectus muscle. No other zebrafish CPA gene exhibited a
similar expression profile. Morpholino-mediated knockdown of CPA6 combined with retrograde labeling and horizontal eye
movement analyses demonstrated that deficiency of CPA6 alone did not affect either VIth nerve development or function in
the zebrafish. We suggest that mutations in other genes and/or enhancer elements, together with defective CPA6
expression, may be required for altered VIth nerve pathfinding. If mutations in CPA6 contribute to Duane syndrome, our
results also suggest that Duane syndrome can be a chondrogenic rather than a myogenic or neurogenic developmental
disorder.
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Introduction
Carboxypeptidase A6 (CPA6) is a member of the M14 family of
carboxypeptidases (CPs) that cleave C-terminal amino acids from
peptides and proteins [1,2]. These enzymes are involved in a wide
variety of biological processes, from food digestion to neuropeptide
maturation and modulation of extracellular signaling factors [3,4].
CPA6 is a member of the A/B subfamily of CPs, members of
which are named based on their substrate specificity, with CPA-
like enzymes cleaving aliphatic/aromatic amino acids, CPB-like
enzymes cleaving basic amino acids, and CPO predicted to cleave
acidic amino acids [2,5]. While the physiological substrates of
CPA6 are not known, human CPA6 is secreted and interacts with
the extracellular matrix where it cleaves a variety of substrates
including proteins, peptides and small synthetic substrates [6].
In contrast to other members of the CPA/B subfamily [3],
which include pancreatic enzymes (CPA1, CPA2, CPB1), a
circulating regulator of fibrinolysis (CPB2/TAFI), and a mediator
of mast cell function (CPA3/mast cell CP), CPA6 has been
suggested to play a role in neuronal development through its
expression in the mouse olfactory bulb, cerebellum and dorsal root
ganglia [1]. The expression of CPA6 posterior to the eye,
suggested to be the lateral rectus muscle [1], has been of particular
interest since a disruption of the human CPA6 gene was
implicated in Duane syndrome [7].
Duane syndrome is a neurodevelopmental disorder in which the
lateral rectus muscle, responsible for abduction of the eye, is not
innervated by the abducens nerve (cranial nerve VI). Rather, in
many cases, the lateral rectus is aberrantly innervated by the
oculomotor nerve (cranial nerve III) [8]. Mutations in several
genes, including CPA6, have been linked to Duane syndrome
[7,9,10,11,12]. The CPA6 gene is located within a genomic locus
named DURS1, previously implicated in Duane syndrome
[13,14]. However, the causative gene at the DURS1 locus has
not been definitively identified.
The possibility that a mutant CPA6 might be responsible for
axon guidance defects leading to Duane syndrome prompted us to
investigate the role of CPA6 in the zebrafish. This model organism
enables the easy determination of developmental gene expression
patterns and quantitative analysis of eye movement following
perturbation of gene expression. Here we describe the cloning of
zebrafish CPA6, its enzymatic activity and mRNA distribution
during embryonic development. Although the expression pattern
of CPA6 is consistent with a role in Duane syndrome, behavioral
data show no effect on eye movement upon CPA6 knockdown.
We propose that CPA6 may be involved in the etiology of Duane
syndrome through expression in a relevant chondrogenic conden-
sation, but dysfunction of additional genes and/or evolutionary
modification of axon guidance is required for the manifestation of
a phenotype.
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Identification and spatiotemporal expression of
carboxypeptidase genes in the zebrafish
In order to study the role of CPA6 in zebrafish development,
particularly the development of the VIth cranial nerve relevant to
Duane syndrome, the zebrafish genome was screened for all A/B-
type CPs using a bioinformatics approach. Two CPB-like genes,
one CPO-like gene, and five CPA-like genes were found based on
similarity to mouse and human sequences (Fig. 1). Most of the
zebrafish CPA/B genes were orthologs of mammalian CPA/B
genes, based on sequence similarity (Fig. 2). No ortholog of
mammalian CPA3 (mast cell carboxypeptidase) was identified by
sequence homology. While zebrafish CPA1 and CPA5 amino acid
sequences were equally similar to both mouse CPA1 and CPA5,
their spatial and temporal expression profiles suggested their
respective identities (described below). The same applied to
zebrafish CPA2 and CPA4. In addition to overall sequence
similarity to mammalian CPA6 orthologs, zebrafish CPA6
contains a methionine (Met387) at a key position in the
substrate-binding pocket (equivalent to residue 255 of mature
bovine CPA1). This methionine is a defining feature of CPA6 in all
known vertebrate orthologs which is not found in other members
of the CP family [1].
Temporal and spatial patterns of expression for all zebrafish
CPA genes were determined by both quantitative RT-PCR and in
situ hybridization. Notably, CPA6 was the major CPA gene
expressed during embryogenesis at 1 and 2 days post-fertilization
(dpf; Fig. 3A). RT-PCR showed CPA6 mRNA to be detectable as
early as 11 hpf (data not shown) and maintained at comparable
levels from 1 to 5 dpf throughout embryonic development (Fig. 3B).
At 2 dpf, CPA6 mRNA was found in the precursors of the
stomodeum and pectoral fins and in a condensation posterior to
the eyes (Fig. 3C). This distribution, particularly near the eyes and
in the pectoral fin buds, is consistent with that seen for CPA6
mRNA in the mouse embryo [1](unpublished data), further
confirming a molecular and functional homology. CPA1 and
CPA2 mRNAs were both highly expressed in the pancreas of
larval zebrafish from 4 dpf (Fig. 3A, B, D), consistent with the
pancreatic distribution of the mammalian orthologs. Although
RT-PCR showed CPA4 mRNA to be weakly expressed at all time
points examined (Fig. 3B), CPA4 mRNA was not detected at any
time point by in situ hybridization. CPA5 mRNA was localized at 2
dpf to a subpopulation of cells recently identified to be mast cells
[15], as well as in the pancreas at 4 dpf (Fig. 3C, D). In fact, both
RT-PCR and in situ hybridization suggest that CPA5 is the
predominant pancreatic CPA in the zebrafish at 3–5 dpf. No other
CPA mRNA was found to have an expression profile overlapping
with that of CPA6 mRNA.
Zebrafish CPA6 is an extracellular carboxypeptidase
To determine the enzymatic properties of zebrafish CPA6, the
cDNA was cloned into pcDNA3.1. EGFP-tagged and untagged
versions were used in subsequent experiments. Upon transfection
into HEK293T cells, mature EGFP-tagged CPA6 (65 kDa) was
detected by western blot in the ECM, while the proenzyme
(78 kDa) was found in cell extracts (Fig. 4A). Unlike that previously
reported for human CPA6, a small amount of CPA6 was detected
in the media, likely due to the presence of the relatively large C-
terminal EGFP tag. The activity of ECM-bound CPA6, both
EGFP-tagged (not shown) and untagged, was measured through a
standard enzyme assay using fa-FF as a substrate. The pH
optimum for zebrafish CPA6 was 7.5–8.0 (Fig. 4B), as previously
reported for human CPA6 [6]. Substrates optimal for human
CPA6 [6] were also found to be optimal for zebrafish CPA6.
Among a series of commercially available substrates, fa-FF and fa–
RL were most rapidly cleaved while small amino acids (alanine)
and those following a penultimate glycine were not favored
(Fig. 4C). Based on the enzymatic properties of CPA6, in addition
to its sequence and expression profile, the identified gene is clearly
the zebrafish ortholog of CPA6.
CPA6 is expressed in non-myogenic tissues in the
zebrafish
A detailed in situ hybridization time series was performed to
determine the spatiotemporal expression profile of CPA6 during
zebrafish development. CPA6 mRNA was first seen at 11 hpf in
the presomitic mesoderm and the most recently formed somites
(Fig. 5A,B). Expression in the somites continued until about 24 hpf
(Fig. 5D), with weak staining detected as late as 30 hpf in the tip of
the tail. At 19 and 24 hpf CPA6 mRNA was also detected in
ectodermal cells of the tail (Fig. 5C,D) and weakly in more anterior
somites (Fig. 5D). CPA6 was first localized posterior to the eyes at
30 hpf, with greatest expression seen between 42 and 48 hpf
(Fig. 5E–H) which was undetectable by 68 hpf (not shown). During
the narrow time window represented by the 42 and 48 hpf time
points, CPA6 mRNA was also found in the precursors of the
stomodeum (Fig. 5G, asterisk) and the pectoral fins (Fig. 5H,
arrowhead). This spatial and temporal pattern of CPA6 gene
expression is summarized in Figure 5I–J.
The presence of CPA6 in a condensation posterior to the eye,
previously found in the mouse and suggested to be the lateral
rectus muscle [1], was of particular interest as CPA6 had been
implicated in Duane syndrome [7]. Double in situ hybridization of
CPA6 with myogenin, a marker of muscle precursors [16], was
performed in order to identify this CPA6-expressing tissue
(Fig. 6A). When CPA6 expression was compared with the location
of extraocular muscle precursors labeled by myogenin [16], it was
clear that CPA6 was beside, but not in, lateral rectus myocytes.
This suggested the identity of this condensation to be chondro-
genic, rather than myogenic, and likely to be the precursor of a
structure called the myodome (see discussion). The ectodermal
CPA6 expression in the pectoral fin bud, rather than in myogenin-
or MyoD-expressing muscle precursors (Fig. 6B), further con-
firmed the localization of CPA6 to non-myogenic tissues during
embryonic development of the zebrafish.
To further confirm the identity of the tissue near the eyes in
which CPA6 is found, two putative markers of the chick lateral
rectus muscle, Meox1 [17] and Lbx1 [18] were investigated.
However, in situ hybridization for the zebrafish ortholog of the
Meox1 gene showed medial extraocular expression at 2 dpf that
clearly was not co-localized with CPA6 mRNA or with myogenin-
expressing lateral rectus precursors (Fig. 6C,E). Likewise, at 2 dpf
the zebrafish ortholog of Lbx1 was found in the anterior hindbrain
as well as in a more lateral group of cells (Fig. 6D, arrow). This
domain of expression was clearly more dorsal to that seen for
CPA6 and for myogenin-expressing lateral rectus muscle precur-
sors (Fig. 6E). It is likely that these two genes, Meox1 and Lbx1,
are not lateral rectus specific markers in the zebrafish.
A closer examination of the distribution of CPA6 in the
zebrafish tail was performed through double in situ hybridization
for CPA6 and MyoD or Twist1b (Fig. 7). MyoD is a transcription
factor expressed first in adaxial cells in the medial presomitic
mesoderm surrounding the notochord [19]. In a 3-somite embryo
(11 hpf, Fig. 7A, top panel), CPA6 mRNA was seen in the lateral
somites but not in the medial MyoD-expressing adaxial cells. At
the 8-somite stage (14 hpf, Fig. 7A, bottom panel), CPA6 was
found in the anterior portion of the most recently formed somites.
CPA6 in Development
PLoS ONE | www.plosone.org 2 September 2010 | Volume 5 | Issue 9 | e12967Figure 1. Members of the A/B subfamily of metallocarboxypeptidases identified in the zebrafish. Amino acid sequences of identified
CPs were aligned using ClustalW. Greater sequence similarity is indicated by darker background, while locations of signal peptide cleavage, as
predicted by SignalP, and of propeptide cleavage, based on experimental evidence for other orthologs, are indicated by a ‘ and #, respectively.
Critical active site residues are numbered above the alignment according to their corresponding site in bovine CPA1. Sequences were obtained from
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muscle cells of the posterior half of each somite [20]. Twist1b is a
marker of the zebrafish tailbud [21], a region containing
progenitor cells which continuously migrate into the presomitic
mesoderm for incorporation into somites [22]. Double in situ
hybridization showed CPA6 to be in the presomitic mesoderm but
not in the Twist1b-expressing progenitor cells of the tail bud
(Fig. 7B). CPA6 was also clearly localized to a population of
regularly arranged ectodermal cells of unknown identity along the
ventral and dorsal edges of the tail (Fig. 7B, see inset). The
distribution of CPA6 in the tail further illustrates non-myogenic
localization and suggests a potential role in regulating migration of
somitic precursors.
Knockdown of zebrafish CPA6 results in normal
horizontal eye movements
Two morpholino antisense oligos were designed to mediate
knockdown of CPA6. Both were splice-blockers against different
exon/intron boundaries (Fig. 8A). RT-PCR using flanking primers
revealed near complete knockdown in 2 dpf zebrafish with 3 ng of
MO-2 or 6 ng of MO-3 (Fig. 8B). This knockdown was confirmed
using quantitative real-time PCR (Fig. S1). Following morpholino
injection embryos appeared grossly indistinguishable from controls
except for frequent yolk-sac edema beginning at 36 hpf and
recovered by 84 hpf (Fig. 8C). As edema is a common side effect of
zebrafish injections, we did not pursue this as a reliable phenotype.
No defects were seen in other tissues normally expressing CPA6,
including the pectoral fin buds and somitic cells, which were
analyzed following staining with DAPI (data not shown).
VIth nerve development was assessed following injection of 3 ng
control or CPA6-specific MO-2 morpholinos into 1-cell Oli-
g2:EGFP embryos, in which abducens motoneurons are labeled
with EGFP from 24 to 58 hpf [23]. As CPA6 was expressed
posterior to the eye during this same time period (24–68 hpf, Fig. 5)
and morpholinos were found to result in .95% knockdown at 48
hpf (Fig. S1), knockdown of CPA6 was expected to result in a
defect in VIth nerve pathfinding if CPA6 was involved. No
changes were observed in the outgrowth or trajectory of the
abducens nerve (results not shown). Abducens motoneurons are
known to complete innervation of the lateral rectus muscle by 72–
80 hpf [24], well within the time period of morpholino efficacy. To
confirm normal development of the VIth nerve upon CPA6
knockdown as suggested in the Olig2:GFP fish, abducens motor
neurons of wild-type fish injected with 3 ng control or CPA6 MO-
2 morpholinos were retrogradely labeled at 8 dpf by DiI injection
into the lateral rectus muscle (Fig. 8D). This labeling indicated the
presence of the VIth nerve at the lateral rectus muscle, the identity
of this nerve being confirmed by the observation of retrogradely
labeled nuclei in rhombomeres 5 and 6 of the hindbrain.
Functional innervation of the lateral rectus muscle was
investigated through the quantification of both slow phase
optokinetic ‘tracking’ and fast phase ‘saccadic’ eye movement
behaviors. In fish, the tracking and saccadic pathways are separate
but converge on the abducens internuclear neurons and abducens
motoneurons in the hindbrain as illustrated in Fig. 9B. Abducens
internuclear neurons project to the contralateral medial rectus
motoneurons/muscle while the abducens motoneurons project to
the ipsilateral lateral rectus muscle directly (Fig. 9B). Because the
majority of the CPA6 morphants were morphologically indistinct
from uninjected controls, optokinetic reflex (OKR) measurements
provided a direct assessment of the general integrity of the
responsible central pathways as well as the motoneuron innerva-
tion of the eye muscle.
OKR was measured in larval zebrafish. As MO-2 (3 ng) and
MO-3 (6 ng) morphants showed maximal CPA6 knockdown (see
Fig. 8B) these were chosen for eye movement analysis at 5 dpf, at
which time lateral rectus muscle innervation was complete and the
OKR was robust [25] (Fig. 9). From 4 dpf onwards, all Ctr-MO (3
or 6 ng), MO-2 (3 ng) and MO-3 (3 ng) injected larvae were
grossly indistinguishable from uninjected controls (Fig. 9A) and
responded to tactile, auditory and visual stimuli with avoidance
behavior (data not shown). Injection of CPA6 morpholino at a
higher dose (6 ng) resulted in a significant number of morphants
continuing to be edemic at 5 dpf (MO-2, ,80%; MO-3, ,30%,
Fig. 9A).
In response to drum velocity steps of 620u/s, all 5 dpf Ctr-MO
and CPA6 morphants exhibited visual tracking of the drum and
resetting saccades (Fig. 9C–F). Spontaneous saccades were also
observed in the dark (data not shown). Eye velocity was quantified
in 947 saccades from 16 animals in 5 treatment paradigms to
investigate the potential effects of CPA6 knockdown. Saccadic
velocity was similar in Ctr-MO (3 or 6 ng), MO-2 (3 ng) and MO-
3 (6 ng; Normal) injected fish. In general, edemic MO-3 (6 ng)
morphants exhibited significantly lower saccadic velocity
(p,0.001) as determined by a two-way ANOVA analysis with
Bonferroni posttests. Within each group of morphants, saccadic
velocity was comparable when produced by either the medial or
lateral rectus muscle (Fig. 9D).
A measurement of OKR tracking performance is the gain (g),
which is the ratio of eye velocity to stimulus velocity [25]. In all
morphants (except 6 ng MO-3, Edemic), the gain ranged from
Figure 2. Phylogenetic tree indicating relationships of mam-
malian and zebrafish A/B-type metallocarboxypeptidases.
Sequences were aligned by ClustalW and .dnd files produced to
construct a phylogenetic tree. Scale bar indicates substitutions per site.
doi:10.1371/journal.pone.0012967.g002
the NCBI or Ensembl databases and correspond to the following accession numbers: zCPB1, ENSDARP00000066831; zCPB2, BC095834; zCPO,
NM001145629; zCPA1, ENSDARP00000024981; zCPA2, ENSDARP00000064203; zCPA4, ENSDARP00000014821; zCPA5, ENSDARP00000034171; zCPA6,
XM001342113.
doi:10.1371/journal.pone.0012967.g001
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previously reported measurements [25]. In edemic MO-3 (6 ng)
morphants, OKR performance was lower than in control cases as
reflected in the reduced saccadic velocity (Fig. 9D) and gain
(Fig. 9F); however, both slow and fast phases were still observed. In
all cases, OKR of both left and right eyes and performance of both
medial and lateral rectus muscles were similar within a group of
CPA6 morphants (Fig. 9). Eye movement analysis was repeated at
8 dpf and the data were statistically similar to the results at 5 dpf
(data not shown). In summary, CPA6 knockdown in zebrafish did
not result in any lateral rectus specific defects in horizontal eye
movement.
Discussion
CPA6 is a well-conserved enzyme among vertebrates in terms
of molecular properties and expression pattern. It is not
duplicated in the zebrafish genome, although the current
zebrafish genome assembly, Zv8, suggests that CPA6 genes exist
on both chromosomes 8 and 24. This annotation is likely caused
Figure 4. Cellular distribution and enzymatic activity of zebrafish CPA6. (A) EGFP-tagged CPA6 (+) or EGFP only (2) were expressed in
HEK293T cells. Media, cell and ECM extracts were resolved by SDS-PAGE and western blotted with an anti-GFP antibody, showing the majority of
processed CPA6-EGFP (asterisk) localized to the ECM. (B) ECM from cells transfected with zCPA6 was incubated with fa-FF at the pH values indicated
or (C) with a range of commercially available fa substrates at pH 7.5. CP activity was determined by a change in substrate absorbance at 336 nm. Error
bars indicate range of duplicate determinations from a representative experiment. Similar results were obtained in two separate experiments.
doi:10.1371/journal.pone.0012967.g004
Figure 3. Temporal and spatial expression of zebrafish CPA genes. (A, B) qPCR was performed using cDNA prepared from zebrafish at the
indicated developmental time points. All values were normalized to b-actin, and are shown in (A) as expression relative to CPA1 mRNA at 2 dpf, or in
(B) as expression of each gene relative to its highest level (100%). (C, D) In situ hybridization was used to determine the spatial distribution of CPA
mRNA expression. (C) At 2 dpf CPA5 mRNA (arrows) was detected in a mast cell population and CPA6 mRNA was seen in precursor tissues found in
the stomodeum, posterior to the eyes, and in the pectoral fin buds. (D) At 4 dpf, mRNA for CPA1, 2, 4, and 5 were expressed in the pancreas.
doi:10.1371/journal.pone.0012967.g003
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genes indicates 100% identity through all coding and non-coding
sequence, including all introns. Zebrafish CPA6 is secreted and
binds tightly to the extracellular matrix, where it is able to cleave
C-terminal hydrophobic amino acids (Fig. 4). These properties
are very similar to those of the human ortholog [6]. The
distribution of CPA6 mRNA in embryonic zebrafish tissues
(Fig. 5) is also largely conserved when compared with that in the
mouse [1]. CPA6 is expressed in both the zebrafish and mouse
apical ectodermal ridge of the pectoral fin/limb buds and
posterior to the eye. Expression of CPA6 during mouse
somitogenesis has not been investigated.
Figure 5. Detailed analysis of CPA6 mRNA expression throughout zebrafish development. In situ hybridization indicated CPA6 mRNA
(purple) is found in newly formed somites (A–D), ectodermal cells of the tail (C,D), a tissue posterior to the eye (E–H, arrows), the stomodeum (G,
asterisk), and the pectoral fins (H, arrowhead). CPA6 expression posterior to both left and right eyes can be seen in F and H. A summary of the spatial
(I) and temporal (J) expression of CPA6 throughout zebrafish development is shown.
doi:10.1371/journal.pone.0012967.g005
CPA6 in Development
PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e12967Figure 6. Distribution of CPA6 mRNA compared with tissue-specific markers at 2 dpf. (A) A general marker of muscle precursors,
myogenin [16], labels most extraocular muscles (orange) by in situ hybridization, but does not co-localize with CPA6 mRNA (purple). (B) Myogenin
mRNA, as well as MyoD mRNA, is also found in the pectoral musculature, unlike CPA6 mRNA which is ectodermal. CPA6 mRNA does not co-localize
with Meox1 (C), or Lbx1 (D), both putative markers of the lateral rectus muscle in the chick, but likely not in the zebrafish. (E) A schematic of a 2 dpf
zebrafish indicates the relative spatial expression of CPA6, myogenin (in lateral rectus), Lbx1 and Meox1. lr, lateral rectus; mr, medial rectus; sr,
superior rectus; ah, adductor hyoideus; cd, constrictor dorsalis; MD, myodome precursors; O.V., otic vesicle.
doi:10.1371/journal.pone.0012967.g006
Figure 7. Distribution of CPA6 mRNA compared with somitogenesis markers. In situ hybridization was performed with RNA probes specific
for (A) CPA6 (purple) and MyoD (orange) at 3 and 8 somite stages (11 and 14 hpf), and (B) CPA6 (purple) and Twist1b (orange) at 24 hpf. Arrows
indicate ectodermal cells arranged along the ventral ridge of the tail and expressing CPA6. The regular arrangement of these cells, also found along
the dorsal ridge, is illustrated in the inset. PSM, presomitic mesoderm; ys ext, yolk-sac extension.
doi:10.1371/journal.pone.0012967.g007
CPA6 in Development
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any of the other four CPA-like enzymes found in the zebrafish
(Fig. 3). Both CPA1 and CPA2 are detected in the pancreas after 3
dpf, consistent with their known roles as pancreatic digestive
enzymes [26]. Although no CPA3 (mast cell carboxypeptidase)
was identified by sequence homology in the zebrafish, CPA5
appears to take on this role, with expression found in a population
of cells recently identified as mast cells [15]. The weak expression
of CPA2 and CPA4 detected by RT-PCR early in development,
and of CPA4 and CPA5 detected by in situ hybridization in the
pancreas later in development, is consistent with previous reports
of weak embryonic expression (of unknown function) of human
orthologs [27,28]. For the most part, each CPA gene exhibits
distributions consistent with its mammalian ortholog, yet distinct
from that of CPA6.
Of particular interest to this study was the conserved expression
of CPA6 posterior to the eye, consistent with a role for CPA6 in
the etiology of Duane syndrome. Although previous observations
suggested that CPA6 was expressed in lateral rectus muscle
precursor cells [1], it is difficult to distinguish these cells from
developing chondrogenic tissue without markers. Based on the
careful analysis of CPA6 distribution in zebrafish, it does not
appear that CPA6 is expressed in lateral rectus muscle precursor
cells or in any other myogenic cell population (Figs. 6 and 7).
Rather, the condensation near the eye in which zebrafish CPA6 is
found is consistent with developing chondrogenic tissue. CPA6 is
found in bony/chondrogenic tissues (basioccipital cartilage,
vertebrae, and ribs) in the mouse also [1]. In teleost fish, the
chondrogenic tissue found next to the lateral rectus muscle
subsequently forms the walls of a compartment known as the
myodome.
The myodome is a hollow tube formed at the base of the teleost
cranium inside the parasphenoid and basioccipital bones caudal to
the eye [29]. Because the lateral rectus muscle is encompassed by
the myodome, the VIth nerve must pass through this structure in
order to innervate its target [30,31]. The myodome appears to be
unique to fishes, but with a possible functional equivalent in the
cavernous and intercavernous sinuses of man [31]. The bones
making up the walls of the myodome have a novel paraxial
mesoderm embryonic origin in the chick, unlike most other
components of the cranium which originate from migratory neural
crest cells [32]. The expression of CPA6 in this tissue suggests a
role for CPA6 in the unique specification of cartilaginous tissue
from paraxial mesoderm which may be linked to a phylogenetic
remodeling of this tissue to enable the VIth nerve to pass and
successfully find its target muscle (see below). However, morpho-
lino-mediated knockdown of CPA6 did not result in any visible
defects in the trajectory of the VIth nerve nor in any behavioral
eye movement defects specific to either the medial or lateral rectus
muscle.
The conserved expression of CPA6 in cartilaginous precursors
posterior to the eye, however, strongly suggests a role in the
development and innervation of the lateral rectus and in the
etiology of Duane syndrome. This conundrum between the
specific localization of CPA6 adjacent to the lateral rectus muscle
and yet lack of a behavioral phenotype upon knockdown might be
Figure 8. Knockdown of CPA6 gene function. (A) Morpholinos were designed to interfere with normal CPA6 mRNA splicing (Ctr-MO: control
morpholino; MO-2 and MO-3: CPA6 specific morpholinos; lines: MO binding sites; arrows: primer binding sites). (B) RT-PCR using RNA extracted from
either uninjected or morpholino-injected embryos (3 ng) showed CPA6-specific knockdown. (C) 48 hpf embryos injected with control morpholino
and CPA6 MO-2. CPA6 morphants exhibited yolk-sac edema. (D) DiI injected into the lateral rectus muscle (LR) of 8 dpf Ctr-MO and MO-2 CPA6-
morphant zebrafish larvae retrogradely labeled the VIth cranial nerve (nVI). Scale bar =40 mm.
doi:10.1371/journal.pone.0012967.g008
CPA6 in Development
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development may have evolved in mammalian systems that
involve the phylogenetic remodeling of cartilaginous/skeletal
elements through the actions of CPA6. Alternatively, CPA6 may
have taken on a role in mammalian axon pathfinding that simply
is not present in teleost fish. Another possibility is that
developmental and molecular characteristics of the abducens
motor neurons and the VIth nerve itself may have evolved. This is
suggested by anatomical differences between teleost and mamma-
lian abducens nuclei. Abducens motoneurons arise from two
nuclei found in hindbrain rhombomeres (r)5 and r6 in the
zebrafish, while mammalian abducens motor neurons arise from
only one nucleus found in r5 [33]. Axons of r5 abducens
motoneurons, the sole population in mammals, may require CPA6
for guidance while axons of r6 motoneurons, when present in
teleost fish, may be able to reach their target in a CPA6-
independent manner and provide guidance for other CPA6-
dependent axons. However, no anatomical or physiological
differences between r5 and r6 abducens motor neurons have yet
to be discovered [34].
Another possibility for the lack of a CPA6 knockdown
phenotype may be the involvement of other genes, acting in a
compensatory manner in the zebrafish, or defective in reported
cases of Duane syndrome but yet undetected. Recent reports
have suggested that CPA6 may not be the sole causative Duane
syndrome gene on chromosome 8, but the duplication of another
more centromeric gene, CHD7, may be involved [35,36]. The
reported chromosomal translocation disrupting the 59 end of the
CPA6 gene in a Duane syndrome patient [7] might also affect
promoter/enhancer elements of neighboring genes. The CPA6
gene is arranged in a head-to-head fashion with the DEPDC2
gene, which encodes a Rac-GEF with broad distribution
throughout the zebrafish head (unpublished results). This gene
is of note due to the recent identification of activating mutations
in the alpha2-chimaerin gene in patients with familial Duane
syndrome [10,37]. Activating mutations in alpha2-chimaerin, a
Rac-GAP, might correspond to decreased expression of
DEPDC2, a Rac-GEF. Decreased expression of both CPA6
and DEPDC2 might produce a cumulative effect resulting in a
Duane syndrome-like phenotype. While this appears to be an
excellent hypothesis, knockdown of the DEPDC2 gene along with
CPA6 in the zebrafish, using specific splice-blocking morpholinos,
did not result in any noticeable defects in eye abduction (data not
shown).
Figure 9. Optokinetic reflex measurement of CPA6 morphants at 5 dpf. (A) Morphology of CPA6 morphants. (B) Schematic illustration of
central neural pathways for either lateral or medial rectus mediated optokinetic tracking and saccades. (C) Representative example of eye position
(blue trace; top panel), fast phase saccades (green hatching; top panel) and slow phase tracking velocity (cyan trace; bottom panel) in response to
620u/s velocity steps optokinetic stimuli (grey trace; bottom panel) at 0.0625 Hz. (D) Quantification of saccadic velocity produced by either the lateral
(orange bars) or medial rectus muscle (grey bars) in CPA6 morphants and controls. Data are presented as mean 6 S.D. (E) Representative eye tracking,
saccades and gain in a MO-2 (3 ng) morphant and corresponding control. (F) Optokinetic reflex in MO-3 (6 ng) morphants and corresponding control.
doi:10.1371/journal.pone.0012967.g009
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syndrome is here supported by its expression in a functionally
unique and relevant chondrogenic precursor. Although knock-
down of CPA6 in zebrafish did not lead to a phenotype specific to
lateral rectus innervation, the conservation of molecular function
and expression of this enzyme across divergent vertebrate species
suggests an important function. Indeed, if CPA6 is found to be
involved in the etiology of Duane syndrome, our data suggest that
this syndrome is not always myogenic or neurogenic, but can also
be a chondrogenic disorder.
Materials and Methods
Ethics Statement
All experiments were performed in strict accordance to standard
guidelines for zebrafish work and approved by the Animal Institute
Committee at Albert Einstein College of Medicine (protocol
#20080311).
Zebrafish care
Zebrafish were maintained under standard conditions as
described previously [38]. Zebrafish embryos were injected with
morpholino oligonucleotides between 1 and 8-cell stages and were
maintained at 28.5uC in egg water [39]. Morpholinos were
obtained from Gene Tools, LLC, and dissolved in distilled water.
Ctl-MO: GeneTools standard control oligo; MO-2: AGAAAA-
TAAGGGACTCACTGTCAAG; MO-3: GAATGAATGAAA-
CACTTACCCGACG.
Cell Culture and Transfection
HEK293T cells (ATCC) were cultured in Dulbecco’s Modified
Eagle’s Medium supplemented with 10% fetal bovine serum and
penicillin/streptomycin at 37uC and 5% CO2. Cells were
transfected with HEKFectin (BioRad) according to the manufac-
turer’s protocol.
Cell lysis and Western Blotting
Medium was removed from plates and cells washed gently with
phosphate buffered saline (PBS). Cells were scraped from the plate
and lysed in 1% SDS. Following removal of all cells, the plate was
washed several times with PBS and extracellular matrix (ECM)
proteins were extracted with hot SDS-PAGE sample buffer added
directly to the plate. Equal volumes of each extract and medium
were run on a 10% SDS polyacrylamide gel (Biorad), proteins
were transferred to nitrocellulose and Western blotting performed
with rabbit anti-GFP primary antibody (1:1000) and IRdye800-
congugated anti-rabbit secondary antibodies (Rockland, 1:3000).
Images were obtained on a LiCor Odyssey imaging system.
Carboxypeptidase Assays
3-(2-furyl)acryloyl-peptide (fa) substrates (Bachem) were dis-
solved in 50 mM Tris-HCl pH 7.5 (at 37uC) and 150 mM NaCl
to a concentration of 0.5 mM. For pH optimum determination,
substrate was dissolved in 50 mM Tris-acetate buffer containing
150 mM NaCl at the indicated pH values. HEK293T cells were
plated in 6-well plates and 24 hours later transfected with CPA6
expression plasmid. Cells were removed 24–48 hours after
transfection and wells washed 3 times with 25 mM Tris pH 7.5
containing 150 mM NaCl. One milliliter CP substrate was added
and plates were incubated with shaking at 37uC in a humid
chamber for 1–6 hours. All assays compared wells in which cells
were transfected with CPA6 expression plasmid with untransfected
wells. Cleavage of substrate was measured by a decrease in
absorbance at 336 nm.
RT-PCR and cloning of cDNAs
RNA was extracted from zebrafish embryos using the RNeasy
Mini kit (Qiagen) according to the protocol for animal tissues.
RNA quality was assessed by formaldehyde gel electrophoresis.
First-strand cDNA synthesis was performed using the Superscript
III First Strand Synthesis System (Invitrogen), followed by
amplification of desired cDNA by PCR with PlatinumH Pfx
DNA polymerase (Invitrogen) using a program of 94u for 3.5 min,
followed by 35 cycles of 94u for 15 s, 55u for 30 s, and 68u for
2 min. Quantitative real-time PCR was performed on an ABI
7900 using Power SYBRH Green PCR master mix (Applied
Biosystems). Data were normalized to b-actin expression and
shown as relative expression using the 2
2DDCT method. For
cloning purposes, primers (sequences available upon request)
contained restriction sites. Amplicons obtained from PCR
reactions were digested with appropriate restriction enzymes and
ligated into a plasmid, followed by verification by sequencing. RT-
PCR for expression analysis was performed using the Superscript
III One-Step RT-PCR kit from Invitrogen.
In Situ Hybridization
Probes for in situ hybridization were generated by in vitro
transcriptionfrom a linearized plasmid template using a Fluorescein
or DIG RNA Labeling Kit (Roche) with T3 or T7 RNA
polymerase, according to the manufacturer’s protocol. Lithium
chloride-precipitated RNA probe was redissolved in water and
quality assessed by formaldehyde gel electrophoresis. Zebrafish
embryos were fixed in 4% paraformaldehyde in PBS overnight at
4uC and processed for in situ hybridization according to standard
protocols [40], using a probe hybridization temperature of 70uC.
Embryos were finally incubated with alkaline phosphatase sub-
strates BM purple (Roche) or INT/BCIP (Roche) in coloration
buffer for 20 minutes to 10 hours at room temperature, reactions
stopped by incubation in 0.1M glycine pH 2.2 for 10 minutes and
embryos transferred to 70% glycerol for imaging.
Retrograde Labeling
5–8 dpf zebrafish were mounted with ventral side up in 1% low-
melting point agarose. DiI (Invitrogen), dissolved in methanol, was
pressure injected into the lateral rectus muscle. 24 hours later
images of the retrogradely labeled abducens nerve were collected
on a LSM 510 confocal microscope.
Horizontal optokinetic reflex (OKR) assessment
At 5 and 8 dpf, larvae were mounted in low-melting agar and
OKR was induced by visual stimuli of 620u/s velocity steps using
a drum with a stripe frequency of 15.5u. [25,41]. Measurement
and data processing was performed using custom routines in
MATLAB (MathWorks, Natick, MA; courtesy of Dr. James Beck)
and Prism (GraphPad Software Inc., La Jolla, CA).
Supporting Information
Figure S1 Knockdown of CPA6 does not significantly affect
expression of other zebrafish CPA genes. Six nanograms of
indicated morpholinos were injected and RNA extracted at 2 dpf.
Real-time PCR indicated near complete knockdown of CPA6 by
both morpholinos. CPA4 and CPA5 mRNAs appeared slightly
affected by MO2 morpholino but not by MO3 morpholino.
Expression of CPA1 and CPA2 mRNAs were not affected by
either morpholino.
Found at: doi:10.1371/journal.pone.0012967.s001 (0.04 MB
TIF)
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